Bump2Baby & Me+ (B2B&Me+): Protocol for a multi-country, European implementation project to reduce the incidence of gestational diabetes mellitus and improve maternal and child health
The Bump2Baby & Me+ (B2B&Me+) project is a multi-country European study employing a hybrid type 3 implementation-effectiveness design to evaluate the reach, adoption, and effectiveness of a personalized mHealth coaching intervention in reducing gestational diabetes mellitus across diverse health systems while developing a scalable implementation toolkit to bridge the evidence-to-practice gap.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine pregnancy as a long, exciting road trip. For most travelers, the journey is smooth, but for about 1-in-7 people, a tricky detour called Gestational Diabetes Mellitus (GDM) pops up. This isn't just a temporary bump in the road; it's like a warning sign that the driver (the mother) might face a much bigger traffic jam later in life called Type 2 diabetes, with a risk 10 times higher than average.
Right now, doctors know that eating better and moving more can clear these detours. But here's the problem: getting people to stick to a diet plan or an exercise routine is like trying to keep a goldfish interested in a bowl of water—it's hard to keep them engaged for the long haul.
Enter Bump2Baby and Me Plus (B2B&Me+). Think of this not as a strict diet coach yelling at you, but as a super-smart, friendly digital companion living in your pocket. This project is a massive, multi-country experiment across Ireland, Spain, Poland, and Norway to see if this digital companion can be successfully plugged into the regular "traffic control" systems of hospitals, rather than just running in a fancy, isolated test lab.
The Big Experiment: ABA Blocks
The researchers aren't just guessing; they are running a specific type of test called a hybrid type 3 implementation study. Imagine a traffic light that changes colors every few months:
- Block A (Red Light): For the first few months, hospitals do things exactly as they always have (Usual Care). While they don't run the new risk screening tool on these women, the researchers still determine their GDM risk status by looking at the data they provide and their medical records.
- Block B (Green Light): Then, they flip the switch! They start using a special Monash machine learning tool to actively scan for risk. If a woman is flagged as "at-risk," she gets invited to join the B2B&Me+ program.
- Block A (Red Light again): Finally, they switch back to the old way to see if the changes stick or if things go back to normal.
This isn't a random coin toss where some people get the app and some don't; instead, the timing and the method of inviting people are what's being tested.
The Four Ways to Say "Hey, Join Us!"
One of the coolest parts of this study is testing four different ways to invite women to join the program, like trying four different keys to see which one opens the door best:
- Point-of-Care (POC): A doctor or nurse says, "Hey, you're at risk, let's set up the app right now!" (Active).
- POC + Follow-up: Same as above, but if you don't sign up immediately, they call you back in 48 hours to help you out.
- Leaflet: You get a cool flyer explaining the app, and you can call to sign up if you want. (Passive).
- Leaflet + Follow-up: You get the flyer, and they call you back in 48 hours to help you sign up.
The team suspects that the active "Point-of-Care" keys will get more people to turn the lock (higher participation rates), but they need the data to prove it.
What's Inside the Digital Backpack?
Once you're in, the Bump2Baby and Me+ app is your personal travel guide. It's not just a static list of rules; it's a living, breathing coach.
- The Gear: You get a Bluetooth-enabled weighing scale (a Medisana BS 444 connect) that talks directly to the app. You step on it, and the data flies straight to your coach.
- The Coach: You get two live video chats (one when you start, one around 8 weeks after the baby is born). If you get diagnosed with GDM during the trip, you get a third chat to adjust your plan.
- The Texts: Between the live chats, you get a steady stream of texts and videos. For the first month, it's weekly. Then it slows down to every two weeks, then monthly until the baby arrives. After the baby is born, it picks up again, checking in every two weeks until 9 months postpartum.
- The Content: It covers everything from healthy eating and moving your body to emotional wellbeing and breastfeeding. It's all tailored to what you need, using science-backed tricks like Motivational Interviewing to help you find your own "why."
The Goal: Not Just "Did it Work?" but "Can We Do It?"
The paper is very clear about what it is and isn't.
- It is NOT a study that claims this app definitely cures diabetes for everyone. The previous trial (B2B&Me) showed promising results (lowering GDM rates from 20.0% to 14.0%), but this new study is asking: "Can we actually make this work in real, busy hospitals?"
- It IS a study measuring Reach, Adoption, Implementation, and Maintenance (using a framework called RE-AIM). They want to know: Did enough people sign up? Did the hospitals like using it? Did the staff get trained? Will they keep using it next year?
They are also crunching the numbers on cost. They want to know the Incremental Cost-Effectiveness Ratio (ICER)—basically, how much extra money does it cost to prevent one case of diabetes using this app compared to doing nothing? They are also doing a Budget Impact Analysis to see if hospitals can afford to keep this running.
The Numbers and the Timeline
The team is aiming to recruit about 600 women into the app across the four countries. They expect to find about 195 at-risk women per site per block.
- Recruitment Start: December 1st, 2025.
- Recruitment End: August 31st, 2026.
- Data Finish: January 2028.
- Results: Expected by May 2028.
They are being very careful. They are excluding women with twins or triplets, those who already have Type 1 or Type 2 diabetes, or anyone who can't speak the local language or doesn't own a smartphone. They are also excluding anyone with severe mental illness or recent heart issues to keep the group safe.
The "So What?"
The researchers admit this isn't a magic wand. They know that digital tools might leave out people who don't have smartphones, and that real-world hospitals are chaotic places where staff are stretched thin. They are using a framework called EPIS (Exploration, Preparation, Implementation, Sustainment) to map out exactly where things might get stuck.
If this works, the end result won't just be a research paper. The team is building a European Implementation Toolkit. Think of this as a "How-To" manual for other hospitals, telling them exactly how to set up their own digital diabetes-prevention programs, how much it costs, and how to keep the staff and patients happy.
In short, this paper is a blueprint for turning a cool, successful app from a science experiment into a standard part of the hospital routine, hoping to keep moms and babies healthier for years to come. It's a big, careful, multi-country effort to see if the digital future of healthcare can actually fit into the messy, beautiful reality of today.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.